FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/01/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
Scott D. Woldow Smith, Gambrell & Russell, LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for treating inflammation conditions and metabolic conditions; pharmaceutical preparations for nutrition, namely, nutritional supplements; veterinary preparations for treating inflammation conditions and metabolic conditions; veterinary preparations for nutrition, namely, nutritional supplements for veterinary purposes; medical preparations for the treatment of inflammation conditions and metabolic conditions; medical preparations for nutrition chemical preparations for nutrition, namely, nutritional supplements for medical purposes; medicated additives for animal foods, namely, animal feed additives for use as nutritional supplements for medical purposes; additives with medicinal effects for feed, namely, animal feed additives for use as nutritional supplements for medical purposes; chemical preparations for inflammation conditions and metabolic conditions for medical, pharmaceutical and veterinary purposes; chemical preparations for nutrition, namely, nutritional supplements for medical, pharmaceutical and veterinary purposes; medicated animal feed; medicated supplements for animal feedstuffs; amino acids for medical and veterinary purposes; cellulose esters for pharmaceutical purposes, medicinal oils and greases for medical and veterinary purposes; salt products, namely, potassium iodide and sodium salts for medical purposes; steroids; biological preparations for the treatment of metabolic disorders for medical and veterinary purposes; ferments for pharmaceutical purposes; yeast dietary supplements; yeast for pharmaceutical purposes; starch for pharmaceutical purposes; enzymes and enzyme preparations, all for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures for medical or veterinary purposes; probiotic supplements; probiotic bacterial preparations for veterinary use; probiotic preparations for medical use featuring bacterial formulations; probiotic supplements for dietetic use; food supplements in the nature of antioxidants; sanitary preparations for medical purposes; dietetic foods adapted for medical and veterinary use; dietetic preparations adapted for medical purposes; dietetic animal foodstuffs for medical purposes; nutritional supplements; albuminous dietetic preparations adapted for medical purposes; medicated confectionery; medicinal drinks; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; medical preparations for slimming purposes; nutritional supplements for humans; dietary supplements for animals; dietetic preparations adapted for medical purposes and for use as dietary supplements; sugar in the nature of candy and glucose for medical purposes; glucose for medical purposes; dietetic albuminous animal foodstuffs for medical purposes; protein dietary supplements; dietary fibre to aid digestion; mineral food supplements; nutritional preparations, namely, nutritional supplements containing trace elements for human and animal use; vitamin preparations; feed supplements in the nature of amino acids for veterinary purposes, synthetic peptides for the treatment of inflammation, metabolic conditions, nutrition deficiency, and protein supplements for use in animal feed, fish food and aquacultures; animal feed supplements, not for medical purposes; nutritional supplements, namely, flavonoids for use as a dietary supplement
Classe 31
Products for aquaculture, namely, aquaculture feed; live animals; foodstuffs and fodder for animals; preparations for use as animal feed; foodstuffs for fish; aquaculture feed; foodstuffs for animals containing botanical extracts; yeast for animal consumption
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
17/01/2025
FINAL DISPOSITION NOTICE SENT TO IB
27/12/2024
FINAL DISPOSITION PROCESSED
27/12/2024
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/10/2024
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/07/2024
REGISTERED-PRINCIPAL REGISTER
16/07/2024
NOTIFICATION PROCESSED BY IB
30/04/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/04/2024
PUBLISHED FOR OPPOSITION
30/04/2024
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/04/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2024
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
25/03/2024
EXAMINER'S AMENDMENT ENTERED
25/03/2024
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/03/2024
EXAMINERS AMENDMENT E-MAILED
25/03/2024
EXAMINERS AMENDMENT -WRITTEN
25/03/2024
PREVIOUS ALLOWANCE COUNT WITHDRAWN
18/03/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
18/03/2024
EXAMINER'S AMENDMENT ENTERED
18/03/2024
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/03/2024
EXAMINERS AMENDMENT E-MAILED
18/03/2024
EXAMINERS AMENDMENT -WRITTEN
18/03/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
18/01/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/01/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/01/2024
REFUSAL PROCESSED BY IB
29/08/2023
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/08/2023
REFUSAL PROCESSED BY MPU
04/08/2023
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/06/2023
NON-FINAL ACTION WRITTEN
27/06/2023
ASSIGNED TO EXAMINER
19/06/2023
APPLICATION FILING RECEIPT MAILED
04/04/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/03/2023
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/03/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.